TNF and inflammatory bowel disease: It is suggested that OpiHi monocytes represent an effective factor for predicting the clinical response to anti-TNF treatment in IBD patients, which could assist physicians in determining whether to use anti-TNF therapy for IBD patients in clinical practice.